Gi Stool Testing Market Size, Growth 2034
Global GI Stool Testing Market Growth, Size, Trends Analysis - By Product, By Test Type, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jun-2025 | Report ID: HLCA25159 | Pages: 1 - 250 | Formats*: |
| Category : Healthcare | |||
Global GI Stool Testing Market Introduction and Overview
According to SPER Market Research, the Global GI Stool Testing Market is estimated to reach USD 1411.55 million by 2034 with a CAGR of 8.06%.
The report includes an in-depth analysis of the Global GI Stool Testing Market, including market size and trends, product mix, Vehicle Type, and supplier analysis. Rising gastrointestinal problems, growing need for non-invasive testing, and improvements in diagnostic technologies are driving the global gastrointestinal (GI) stool testing market, a fast-growing section of the diagnostic industry. The rising incidence of diseases like colon cancer, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and parasite infections are important contributors. Additionally, advancements in multiplex assays, microbiome profiling, and molecular diagnostics are driving the market. The stool testing market is expected to increase steadily due to factors such aging populations, rising health consciousness, and better access to healthcare, particularly in emerging nations.
By Product Insights
The market is divided into consumables and analyzers based on the kind of product. In 2024, the consumables division generated the most income.
Reagents, test kits, and sample collecting equipment are the consumables with the biggest market shares. Because they are essential for carrying out precise and trustworthy testing, labs and medical facilities are always in need of these items. By lowering the chance of cross-contamination, the increasing use of disposable consumables guarantees adherence to strict infection control procedures.
By Test Type Insights
The market for GI stool testing includes a variety of test types, including ova and parasite tests, fecal biomarker tests, bacteria tests, and occult blood tests. By 2034, the market for occult blood tests is expected to propel company expansion and growth at an astounding rate. Leading the industry, occult blood tests are essential for detecting colorectal cancer and gastrointestinal bleeding early.
By Application Insights
Application-based market categories for GI stool tests include GERD, cancer, inflammatory bowel disease, infection, and others. It is projected that the infection category will rise significantly and propel corporate expansion by 2034.
Due to the increasing incidence of gastrointestinal infections brought on by bacteria, viruses, and parasites, the infection category accounts for a sizeable portion of the GI stool testing market.
By Regional Insights
The United States' GI stool testing market was the market leader in 2024 and is predicted to increase at a significant compound annual growth rate (CAGR) between 2025 and 2034.
The primary drivers propelling the market in the United States are the robust healthcare system and the extensive use of preventive healthcare practices. As colorectal cancer cases have increased due to initiatives, stool testing has become more widespread.
Market Competitive Landscape
The market for GI stool testing is changing quickly due to new developments in technology and shifting consumer tastes. Stool testing has become more accurate thanks to the incorporation of molecular diagnostics, which makes it possible to identify particular pathogens, genetic markers, and cancer signs. Some of the key market players are Abbott, Danaher, Bio-Rad, bioMérieux, Cardinal Health, Cenogenics, CTK Biotech, DiaSorin, EDI (Epitope Diagnostics), Genova Diagnostics.
Recent Developments:
In February 2024, Reese Pharmaceutical introduced ColoTest, an FDA-approved, over-the-counter, at-home fecal immunochemical test (FIT) to detect concealed blood in stool, a potential early indicator of colon cancer, and other gastrointestinal issues.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Test Type, By Applications |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Abbott, Danaher, Bio-Rad, bioMérieux, Cardinal Health, Cenogenics, CTK Biotech, DiaSorin, EDI (Epitope Diagnostics), Genova Diagnostics. |
Key Topics Covered in the Report
- Global GI Stool Testing Market Size (FY’2021-FY’2034)
- Overview of Global GI Stool Testing Market
- Segmentation of Global GI Stool Testing Market By Product (Consumables, Analyzers)
- Segmentation of Global GI Stool Testing Market By Test Type (Occult blood test, Bacteria Test, Fecal biomarkers test, Ova and parasites test, Other test types)
- Segmentation of Global GI Stool Testing Market By Applications (Infection, Cancer, Inflammatory bowel disease, Gastroesophageal reflux disease (GERD), Other applications)
- Statistical Snap of Global GI Stool Testing Market
- Expansion Analysis of Global GI Stool Testing Market
- Problems and Obstacles in Global GI Stool Testing Market
- Competitive Landscape in the Global GI Stool Testing Market
- Details on Current Investment in Global GI Stool Testing Market
- Competitive Analysis of Global GI Stool Testing Market
- Prominent Players in the Global GI Stool Testing Market
- SWOT Analysis of Global GI Stool Testing Market
- Global GI Stool Testing Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global GI Stool Testing Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global GI Stool Testing Market
7.Global GI Stool Testing Market, By Product (USD Million) 2021-2034
7.1.Consumables7.2.Analyzers
8.Global GI Stool Testing Market, By Test Type (USD Million) 2021-2034
8.1.Occult blood test8.2.Bacteria Test8.3.Fecal biomarkers test8.4.Ova and parasites test8.5.Other test types
9.Global GI Stool Testing Market, By Applications (USD Million) 2021-2034
9.1.Infection9.2.Cancer9.3.Inflammatory bowel disease9.4.Gastroesophageal reflux disease (GERD)9.5.Other applications
10.Global GI Stool Testing Market, (USD Million) 2021-2034
10.1.Global GI Stool Testing Market Size and Market Share
11.Global GI Stool Testing Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific
11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle East and Africa
11.4.North America
11.4.1.Canada11.4.2.Mexico11.4.3.United States
11.5.Latin America
11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1.Abbott
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2.Danaher
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3.BIO RAD
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4.BIOMRIEUX
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5.CardinalHealth
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6.Cenogenics
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7.CTK BIOTECH
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8.Diasorin
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9.EDI
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10.GENOVA DIAGNOSTICS
12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments
12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Gi Stool Testing Market is projected to reach USD 1411.55 million by 2034, growing at a CAGR of of 8.06% during the forecast period.
Gi Stool Testing Market grew in Market size from 2025. The Market is expected to reach USD 1411.55 million by 2034, at a CAGR of 8.06% during the forecast period.
Gi Stool Testing Market CAGR of 8.06% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Gi Stool Testing Market size is USD 1411.55 million from 2025 to 2034.
Gi Stool Testing Market is covered By Product, By Test Type, By Applications
The North America is anticipated to have the highest Market share in the Gi Stool Testing Market.
Abbott, Danaher, Bio-Rad, bioMérieux, Cardinal Health, Cenogenics, CTK Biotech, DiaSorin, EDI (Epitope Diagnostics), Genova Diagnostics.
The report includes an in-depth analysis of the Global GI Stool Testing Market, including market size and trends, product mix, Vehicle Type, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
